Neurosarcoidosis: pathophysiology, diagnosis, and treatment

MJ Bradshaw, S Pawate, LL Koth, TA Cho… - Neurology …, 2021 - AAN Enterprises
Although often regarded as a protean illness with myriad clinical and imaging
manifestations, neurosarcoidosis typically presents as recognizable syndromes that can be …

Neurosarcoidosis: clinical manifestations, investigation and treatment

DP Kidd - Practical Neurology, 2020 - pn.bmj.com
Sarcoidosis affects the nervous system in 10% of cases. When it does so it can affect any
part of the nervous system and with all degrees of severity. It forms part of the differential …

[HTML][HTML] Neurosarcoidosis: a clinical approach to diagnosis and management

RT Ibitoye, A Wilkins, NJ Scolding - Journal of neurology, 2017 - Springer
Sarcoidosis is a rare but important cause of neurological morbidity, and neurological
symptoms often herald the diagnosis. Our understanding of neurosarcoidosis has evolved …

Insights into non-classic and emerging causes of hypopituitarism

F Prodam, M Caputo, C Mele, P Marzullo… - Nature Reviews …, 2021 - nature.com
Hypopituitarism is defined as one or more partial or complete pituitary hormone deficiencies,
which are related to the anterior and/or posterior gland and can have an onset in childhood …

[HTML][HTML] Pituitary stalk thickening: Causes and consequences. the children's memorial health institute experience and literature review

E Moszczyńska, K Kunecka… - Frontiers in …, 2022 - frontiersin.org
Background Pituitary stalk thickening (PST) is a rare abnormality in the pediatric population.
Its etiology is heterogeneous. The aim of the study was to identify important clinical …

Diagnosis of endocrine disease: expanding the cause of hypopituitarism

S Pekic, V Popovic - European journal of endocrinology, 2017 - academic.oup.com
Hypopituitarism is defined as one or more pituitary hormone deficits due to a lesion in the
hypothalamic–pituitary region. By far, the most common cause of hypopituitarism associated …

[HTML][HTML] Clinical characterization and outcomes of 85 patients with neurosarcoidosis

M Ramos-Casals, R Pérez-Alvarez, B Kostov… - Scientific Reports, 2021 - nature.com
To analyze the frequency and clinical phenotype of neurosarcoidosis (NS) in one of the
largest nationwide cohorts of patients with sarcoidosis reported from southern Europe. NS …

Hypophysitis (including IgG4 and immunotherapy)

A Angelousi, K Alexandraki, M Tsoli, G Kaltsas… - …, 2020 - karger.com
Hypophysitis is characterized by inflammation of the pituitary gland that can be primary (PH)
or secondary (SH) to other diseases or following drug administration. It may also be …

Neurosarcoidosis

DP Kidd - Journal of Neurology, 2024 - Springer
Sarcoidosis affects the nervous system in 5% of cases. 60% of cases involve the cranial and
peripheral nerves, the remainder the central nervous system, in which a leptomeningitis, a …

Pituitary dysfunction in granulomatosis with polyangiitis

A Vega-Beyhart, IR Medina-Rangel… - Clinical …, 2020 - Springer
Granulomatosis with polyangiitis (GPA) is a necrotizing granulomatous vasculitis of small
vessels that affect the pituitary gland in less than 1% of cases being exceptionally rare. To …